Baltimore, Md.—June 09, 2010—Med-IQ, an ACCME-accredited provider of continuing medical education (CME), announces the launch of a complimentary, certified CME Webcast series, Mitigating the Risk of Chemotherapy-Associated Cardiotoxicity in Breast Cancer.

Consisting of a comprehensive, didactic presentation, two interactive patient case studies, and an expert-led discussion, this multi-module, Web-based series explores the latest guideline-based recommendations to monitor and manage chemotherapy-associated cardiotoxicity in patients with breast cancer and provides strategies to help coordinate patient care between oncologists and cardiologists.

Scientific advances in the field of breast cancer have led to the diagnosis of cancer at earlier stages and the development of superior treatment strategies. These improvements have translated to better survival rates for patients with breast cancer and, as a result, the long-term side effects of breast cancer treatment have become an increasingly significant factor in patient outcomes.

“Although cardiotoxicity is a notable side effect of several chemotherapeutic agents commonly used to treat breast cancer, clear guidelines do not exist to help physicians assess risk and monitor and manage cardiotoxicity in patients with breast cancer,” says series faculty chair, Sandra M. Swain. “This educational series is designed to help increase awareness and understanding of chemotherapy-associated cardiotoxicity in patients with breast cancer by reviewing best-practice recommendations for assessing risk, implementing appropriate diagnostic and monitoring strategies, and developing patient-specific treatment plans based on recent clinical trial evidence to improve patient care.”

Participants can view this complimentary, certified CME Webcast series today or learn more by visiting www.Med-IQ.com/M5.

Participants can receive up to 2.0 AMA PRA Category 1 Credits™ for completing this series, which is supported by an educational grant from sanofi-aventis U.S.

About Med-IQ

Med-IQ, America's most respected continuing medical education (CME) company, is an accredited provider of CME that educates and inspires healthcare professionals through activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. To learn more about us, visit www.Med-IQ.com.

For more information, contact:

Catherine B. Mullaney, MHA
Vice President, Educational Partnerships
Med-IQ
443 543 5154
info@med-iq.com